August 19, 2014 Northeastern University has received a five-year, $1.15 million grant from the National Institute of Health’s National Cancer Institute to train the next... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- 2014 Student Scientific Presentations - DF/HCC CURE Research Training Program Posted: 07-30-14
- Boston Area Gene Expression Meeting 2014 Posted: 07-29-14
- The DF/HCC High-Throughput Polymorphism Detection Core adds targeted sequencing service Posted: 07-16-14
Latest Cancer News
Glorian Sorensen PhD, MPH (DFCI) was recently awarded $200,000 from the National Cancer Institute (NCI) to promote research collaborations with institutions in low-... | [more]
UMass Boston and DF/HCC have a U54 Partnership grant with NCI/CRCHD to develop life sciences and CPCT on the UMass Boston campus. Read the Spotlight: ... | [more]